Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Biotin carboxylase is a highly conserved enzyme domain central to the catalysis of biotin-dependent carboxylases such as acetyl-CoA carboxylase, propionyl-CoA carboxylase, pyruvate carboxylase, methylcrotonyl-CoA carboxylase, and urea carboxylase. This domain catalyzes the ATP-dependent carboxylation of biotin, a critical step in the transfer of carboxyl groups to various substrates as part of multi-domain enzyme complexes. Biotin carboxylase activity is essential for pathways including fatty acid biosynthesis, gluconeogenesis, amino acid metabolism, and others. As a drug target, its inhibition has therapeutic and agrochemical potential, especially via targeting the broader carboxylase complexes it is part of. Mutations or inhibition of these enzymes can have clinical significance in cancer, metabolic syndromes, congenital disorders, and infectious diseases.
Inhibition of the carboxylation reaction: Drugs/herbicides inhibit ATP-dependent carboxylation of biotin, blocking fatty acid biosynthesis or related pathways
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Biotin carboxylase enzyme (BC).